Substance P and calcitonin gene-related neuropeptides as novel growth factors for ex vivo expansion of cord blood CD34⁺ hematopoietic stem cells

References

• Barker JN, Wagner JE. 2003. Umbilical cord blood transplantation: Current practice and future innovations. Crit Rev Oncol Hematol. 48 1: 35–43.
   PubMedGoogle Scholar
• Boxall SA, Cook GP, Pearce D, Bonnet D, El-Sherbiny YM, Blundell MP, . 2008. Haematopoietic repopulating activity in human cord blood CD133(+) quivhescent cells. Bone Marrow Transplant. 43:627–635.
   PubMedGoogle Scholar
• Bracci-Laudiero L, Celestino D, Starace G, Antonelli A, Lambiase A, Procoli A, . 2003. CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J Neuroimmunol. 136 1–2: 130–139.
   PubMedGoogle Scholar
• Broome CS, Miyan JA. 2000. Neuropeptide control of bone marrow neutrophil production. A key axis for neuroimmunomodulation. Ann N Y Acad Sci. 917:424–434.
   PubMedGoogle Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, . 1989. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 86 10: 3828–3832.
   PubMed Web of Science ®Google Scholar
• Charrier S, Boiret N, Fouassier M, Berger J, Rapatel C, Pigeon P, . 2002. Normal human bone marrow CD34(+)CD133(+) cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro. Exp Hematol. 30 9: 1051–1060.
   PubMedGoogle Scholar
• Eridani S, Mazza U, Massaro P, La Targia ML, Maiolo AT, Mosca A. 1998. Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources. Biotherapy. 11 4: 291–296.
   PubMedGoogle Scholar
• Fernandez MN, Regidor C, Cabrera R, Garcia-Marco J, Briz M, Fores R, . 2001. Cord blood transplants: Early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant. 28 4: 355–363.
   PubMed Web of Science ®Google Scholar
• Gilmore GL, DePasquale DK, Lister J, Shadduck RK. 2000. Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells. Exp Hematol. 28 11: 1297–1305.
   PubMed Web of Science ®Google Scholar
• Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, . 1998. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry. 34 3: 128–142.
   PubMedGoogle Scholar
• Greco SJ, Corcoran KE, Cho KJ, Rameshwar P. 2004. Tachykinins in the emerging immune system: Relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci. 9:1782–1793.
   PubMed Web of Science ®Google Scholar
• Harzenetter MD, Keller U, Beer S, Riedl C, Peschel C, Holzmann B. 2002. Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp Hematol. 30 4: 306–312.
   PubMedGoogle Scholar
• Hiramoto M, Aizawa S, Iwase O, Nakano M, Toyama K, Hoque M, . 1998. Stimulatory effects of substance P on CD34 positive cell proliferation and differentiation in vitro are mediated by the modulation of stromal cell function. Int J Mol Med. 1 2: 347–354.
   PubMedGoogle Scholar
• Irie K, Hara-Irie F, Ozawa H, Yajima T. 2002. Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech. 58 2: 85–90.
   PubMed Web of Science ®Google Scholar
• Kaushansky K, Karplus PA. 1993. Hematopoietic growth factors: Understanding functional diversity in structural terms. Blood. 82 11: 3229–3240.
   PubMedGoogle Scholar
• Kawakami M, Kimura T, Kishimoto Y, Tatekawa T, Baba Y, Nishizaki T, . 2004. Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38 − cells: Possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells. Leukemia. 18 5: 912–921.
   PubMedGoogle Scholar
• Kohler T, Plettig R, Wetzstein W, Schaffer B, Ordemann R, Nagels HO, . 1999. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells. 17 1: 19–24.
   PubMed Web of Science ®Google Scholar
• Li Y, Douglas SD, Ho W. 2000. Human stem cells express substance P gene and its receptor. J Hematother Stem Cell Res. 9 4: 445–452.
   PubMedGoogle Scholar
• Liu K, Castillo MD, Murthy RG, Patel N, Rameshwar P. 2007. Tachykinins and hematopoiesis. Clin Chim Acta. 385 1–2: 28–34.
   PubMed Web of Science ®Google Scholar
• Madkaikar M, Ghosh K, Gupta M, Swaminathan S, Mohanty D. 2007. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol. 118 3: 153–159.
   PubMedGoogle Scholar
• McGuckin CP, Pearce D, Forraz N, Tooze JA, Watt SM, Pettengell R. 2003. Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol. 71 5: 341–350.
   PubMedGoogle Scholar
• McGuckin CP, Forraz N, Pettengell R, Thompson A. 2004. Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells. Cell Prolif. 37 4: 295–306.
   PubMedGoogle Scholar
• Mohamed AA, Ibrahim AM, El-Masry MW, Mansour IM, Khroshied MA, Gouda HM, . 2006. Ex vivo expansion of stem cells: Defining optimum conditions using various cytokines. Lab Hematol. 12 2: 86–93.
   PubMedGoogle Scholar
• Nowicki M, Ostalska-Nowicka D, Kondraciuk B, Miskowiak B. 2007. The significance of substance P in physiological and malignant haematopoiesis. J Clin Pathol. 60 7: 749–755.
   PubMed Web of Science ®Google Scholar
• Rameshwar P, Gascon P. 1995. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood. 86 2: 482–490.
   PubMed Web of Science ®Google Scholar
• Rameshwar P, Ganea D, Gascon P. 1993. In vitro stimulatory effect of substance P on hematopoiesis. Blood. 81 2: 391–398.
   PubMed Web of Science ®Google Scholar
• Rameshwar P, Zhu G, Donnelly RJ, Qian J, Ge H, Goldstein KR, . 2001. The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: An understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell. J Neuroimmunol. 121 1–2: 22–31.
   PubMedGoogle Scholar
• Robinson S, Niu T, de Lima M, Ng J, Yang H, McMannis J, . 2005. Ex vivo expansion of umbilical cord blood. Cytotherapy. 7 3: 243–250.
   PubMed Web of Science ®Google Scholar
• Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, . 2002. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 8 7: 368–376.
   PubMed Web of Science ®Google Scholar
• da Silva CL, Gonçalves R, Crapnell KB, Cabral JMS, Zanjani ED, Almeida-Porada G. 2005. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol. 33 7: 828–835.
   PubMed Web of Science ®Google Scholar
• Weihe E, Nohr D, Michel S, Muller S, Zentel HJ, Fink T, . 1991. Molecular anatomy of the neuro-immune connection. Int J Neurosci. 59 1–3: 1–23.
   PubMed Web of Science ®Google Scholar
• Wu H, Guan C, Qin X, Xiang Y, Qi M, Luo Z, . 2007. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation. Pulm Pharmacol Ther. 20 5: 513–524.
   PubMedGoogle Scholar
• Yaraee R, Ebtekar M, Ahmadiani A, Sabahi F. 2003. Neuropeptides (SP and CGRP) augment pro-inflammatory cytokine production in HSV-infected macrophages. Int Immunopharmacol. 3 13–14: 1883–1887.
   PubMedGoogle Scholar